12.17.25 -- How AI Is Rewriting Tech Transfer Timelines

Novel therapeutics are driving demand for alternative drug delivery methods. Explore the latest approaches and understand the formulation challenges and benefits for specific diseases.

Discover how a strategic CDMO can safely accelerate high-potency compounds with advanced containment, precise tech transfer, and solutions to complex manufacturing challenges.

New materials, smart automation, and in-press quality control are optimizing tablet compression. These five key innovations are driving efficiency and consistency in solid dose manufacturing today.

The FDA has issued a final guidance, Considerations for Waiver Requests for pH Adjusters in Generic Drug Products Intended for Parenteral, Ophthalmic, or Otic Use.

Laboratory testing services for biopharmaceutical development often are outsourced, but insourcing offers sponsors greater control and stability by combining provider expertise with sponsor infrastructure.

This paper highlights how the roller compaction process not only enhances efficiency but also improves the scalability of solid oral dosage production, supporting rapid development for regulatory approval.

Nanoparticle engineering has emerged as a promising solution for enhancing drug solubility and bioavailability and improving efficiency within the drug development pipeline.

Consider this formulation development workflow for mAbs to provide a more efficient process, driving down costs and reducing timelines, without compromising on quality and hence patient safety.

Choose an experienced CDMO specializing in high-potency softgels and liquids to ensure high-quality products, responsive service, and reliable solutions across complex therapeutic areas.

Our analytical services deliver rapid, precise method development using advanced chromatographic, spectroscopic, and mass-spectrometric solutions for diverse compounds.

From world-class facilities across North America and Asia, high-quality drug products are manufactured and supplied to over 100 global markets, supporting patient and healthcare needs.

For poorly soluble drugs, overcoming absorption hurdles can hinder development. Explore a solution that empowers researchers to overcome solubility limitations and accelerate drug development.

Highly Potent APIs and cytotoxic compounds are crucial components in treating disease. Obtain specialized expertise for these materials to ensure safety and security.

Solid form selection considers chemical makeup and crystal structure, supported by efficient workflows that assess and choose optimal forms to meet each program’s needs.